Levels of TNF-a in blood serum and BALF from children with bronchiolitis obliterans depending on severity of disease Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005
Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS) Source: Eur Respir J 2006; 28: Suppl. 50, 120s Year: 2006
Inflammatory markers in serum and lavage fluid in young adult’s patients with postinfectious bronchiolitis obliterans Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008
Sputum RANTES and eosinophilia is associated with the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004
Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome? Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008
HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015
Possible role of CCL19, CCL20 and CCL22 in post transplant bronchiolitis obliterans Source: Eur Respir J 2005; 26: Suppl. 49, 705s Year: 2005
Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011
Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats Source: Eur Respir J 2007; 30: Suppl. 51, 517s Year: 2007
Ten–years longitudinal study of lung function parameters and elastase activity in lavage fluid in young patients with chronic bronchiolitis obliterans (CBO) Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
Aberrant metalloprotease expression and activity in bronchoalveolar lavage fluid of bronchiolitis obliterans patients Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013
Calprotectin as new sensitive marker of neutrophilic inflammation in patients with bronchiolitis obliterans Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Concentrations of IL4Ra and TNFa in bronchoalveolar lavage fluid can distinguish hypersensitivity pneumonitis from other fibrosing interstitial lung diseases Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2016 – Clinical aspects of ILD Year: 2016